Report Scope & Overview:

The Specialty PACS Market Size was valued at USD 3.09 billion in 2022, and expected to reach USD 5.15 billion by 2030, and grow at a CAGR of 6.6% over the forecast period 2023-2030.

PACS is a type of imaging technology that facilitates the transfer of images from the spot where they were captured to numerous physically distant sites. This technology is cost-effective since it eliminates the need for film and makes it simple to access several imaging modalities at once, including ultrasound, CT, MRI, and radiography, at different places throughout hospitals. Any radiological modality utilised for an image storage device or server for short- or long-term data storage is included in the integration of input from digital or digitised analogue instruments.

Specialty PACS Market Revenue Analysis

To get more information on Specialty PACS Market - Request Sample Report

The fact that a patient can have radiological tests done at many places without having to travel to see numerous radiologists or treating doctors is advantageous. Images captured by PACS are saved in an archive from whence they are retrieved or fetched and shown for review on a reviewing station after being integrated via network infrastructures.



  • Increasing Government Efforts to Promote the Use of Healthcare IT Solutions

  • Investments in Medical Imaging are Growing

  • Increasing Adoption of IT Solutions for Medical Imaging

  • Growing Use of Imaging Technology

  • Growing Geriatric Population and the Incidence of Various Diseases as a Result

  • Favorable Features of Specialty PACS


  • Concerns about data security and privacy

  • Budgetary


  • Artificial Intelligence and Specialty PACS Solutions Integration

  • Growth Prospects Provided by Cloud-Based Specialty PACS Solutions

  • EMR and PACS Integration

  • The utilization of blockchain in clinical imaging


  • Lack of awareness


Numerous pharmaceutical firms and sectors were also affected by the COVID-19 pandemic. The COVID-19 pandemic outbreak has had an impact on the speciality PACS market, healthcare facilities, their supply chain, and decreased demand for PACS devices. Due to the closure of certain industries, it mostly affected big players in the speciality PACS market, who suffered financial losses. In general, COVID-19 had a detrimental effect on the speciality PACS market. This was linked to disruptions in manufacturing, raw material imports and export, and finished goods supply due to shutdowns in several COVID-19-affected nations and an increase in the number of healthcare workers getting sick from the pandemic. Additionally, a decrease in patient hospital visits had an effect on market expansion. Nevertheless, throughout the period following COVID-19, this condition is anticipated to alter.

By Type

The specialty PACS market is categorized into radiology PACS, cardiology PACS, pathology PACS, ophthalmology PACS, orthopedics PACS, oncology PACS, dermatology PACS, neurology PACS, endoscopy PACS, women’s health PACS, and other specialty PACS. The market's greatest share belonged to the radiology PACS sector, but the ophthalmology PACS segment is anticipated to grow at the highest CAGR throughout the forecast period. The increasing frequency of eye diseases and disorders, the growing number of ocular surgeries performed, and technical improvements in ophthalmology devices are some of the reasons driving the expansion of this market.

By Deployment Model

The market is split into on-premise and web/cloud-based specialty PACS. The on-premise category is likely to account for the greatest proportion of the market. This is explained by the fact that on-premise systems, as opposed to web/cloud-based specialist PACS, are more easily customized.

By End-User

The hospital, the ambulatory surgical center (ASC), the clinic, the diagnostic center, and other sections of end users form a medical market. During forecasting, this segment is expected to grow rapidly due to a number of important factors, including increased patient numbers, increased patient awareness of the benefits of early diagnosis, technological advancement in thought processes, increased patient digital integration. data, and rapid growth in EMR acceptance.


By Type

  • Radiology PACS

  • Pathology PACS

  • Cardiology PACS

  • Ophthalmology PACS

  • Oncology PACS

  • Dermatology PACS

  • Orthopedics PACS

  • Endoscopy PACS

  • Neurology PACS

  • Women’s health PACS

By Deployment Model

  • On-premise specialty PACS

  • Web/Cloud-based specialty PACS

By End-User

  • Hospitals

  • Ambulatory Surgery Centers & Clinics

  • Diagnostic Imaging Centers

Specialty PACS Market Segmentation Analysis

Need any customization research on Specialty PACS Market - Enquiry Now


Increasing medical imaging volumes, a large number of diagnostic imaging facilities, an ageing population, and the quick uptake of technologically advanced imaging systems are just a few of the factors that helped North America control the largest portion of the market. But during the course of the projection period, Asia Pacific is anticipated to develop at the greatest CAGR. The market in this region is expanding as a result of factors like the rising prevalence of chronic diseases, growing public awareness of the advantages of early disease diagnosis, and expanding use of imaging modalities.


  • North America

    • USA

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • The Netherlands

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • south Korea

    • China

    • India

    • Australia

    • Rest of Asia-Pacific

  • The Middle East & Africa

    • Israel

    • UAE

    • South Africa

    • Rest of Middle East & Africa

  • Latin America

    • Brazil

    • Argentina

    • Rest of Latin America


Some of the major key players are as follows: Canon Inc., McKesson Corporation, INC Escalon Medical Corp., Eye PACS, LLC, IBM Corporation, INFINITT Healthcare Co. Ltd., Novarad, Onex Corporation (Carestream Health), Siemens AG, Koninklijke Philips N.V. and Other Players

Specialty PACS Market Report Scope:
Report Attributes Details
Market Size in 2022  US$ 3.09 Billion
Market Size by 2030  US$ 5.15 Billion
CAGR   CAGR of 6.6% From 2023 to 230
Base Year  2022
Forecast Period  2023-2030
Historical Data  2020-2021
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Type (Radiology PACS, Pathology PACS, Cardiology PACS, Ophthalmology PACS, Oncology PACS, Dermatology PACS, Orthopedics PACS, Endoscopy PACS, Neurology PACS, Women’s health PACS)
• By Deployment Model (On-premise specialty PACS, Web/Cloud-based specialty PACS)
• By End-User (Hospitals, Ambulatory Surgery Centers & Clinics, Diagnostic Imaging Centers)
Regional Analysis/Coverage North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles anon Inc., McKesson Corporation, INC Escalon Medical Corp., Eye PACS, LLC, IBM Corporation, INFINITT Healthcare Co. Ltd., Novarad, Onex Corporation (Carestream Health), Siemens AG, Koninklijke Philips N.V.
DRIVERS • Increasing Government Efforts to Promote the Use of Healthcare IT Solutions
• Investments in Medical Imaging are Growing

• Increasing Adoption of IT Solutions for Medical Imaging
RESTRAINTS • Concerns about data security and privacy
• Budgetary

Frequently Asked Questions

Ans: The market is expected to reach USD 5.15 billion by 2030.

Ans: The market is grown at a CAGR of 6.6% From 2023 to 2030.

  • Artificial Intelligence and Specialty PACS Solutions Integration
  • Growth Prospects Provided by Cloud-Based Specialty PACS Solutions

Ans: The major players are Canon Inc., McKesson Corporation, INC Escalon Medical Corp., Eye PACS, LLC, IBM Corporation, INFINITT Healthcare Co. Ltd., Novarad, Onex Corporation (Carestream Health), Siemens AG, Koninklijke Philips N.V., and others in the final report.

Ans: The forecast period of the Specialty PACS Market is 2022-2030.

Table of Contents


1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions


2. Research Methodology


3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges


4. Impact Analysis

4.1 COVID-19 Impact Analysis

4.2 Impact of Ukraine- Russia war

4.3 Impact of ongoing Recession

4.3.1 Introduction

4.3.2 Impact on major economies US Canada Germany France United Kingdom China Japan South Korea Rest of the World


5. Value Chain Analysis


6. Porter’s 5 forces model


7.  PEST Analysis


8. Specialty PACS Market Segmentation, By Type

8.1 Radiology PACS

8.2 Pathology PACS

8.3 Cardiology PACS

8.4 Ophthalmology PACS

8.5 Oncology PACS

8.6 Dermatology PACS

8.7 Orthopedics PACS

8.8 Endoscopy PACS

8.9 Neurology PACS

8.10 Women’s health PACS


9. Specialty PACS Market Segmentation, By Deployment Model

9.1 On-premise specialty PACS

9.2 Web/Cloud-based specialty PACS


10. Specialty PACS Market Segmentation, By End-User

10.1 Hospitals

10.2 Ambulatory Surgery Centers & Clinics

10.3 Diagnostic Imaging Centers


11. Regional Analysis

11.1 Introduction

11.2 North America

11.2.1 USA

11.2.2 Canada

11.2.3 Mexico

11.3 Europe

11.3.1 Germany

11.3.2 UK

11.3.3 France

11.3.4 Italy

11.3.5 Spain

11.3.6 The Netherlands

11.3.7 Rest of Europe

11.4 Asia-Pacific

11.4.1 Japan

11.4.2 South Korea

11.4.3 China

11.4.4 India

11.4.5 Australia

11.4.6 Rest of Asia-Pacific

11.5 The Middle East & Africa

11.5.1 Israel

11.5.2 UAE

11.5.3 South Africa

11.5.4 Rest

11.6 Latin America

11.6.1 Brazil

11.6.2 Argentina

11.6.3 Rest of Latin America


12.Company Profiles

12.1 Canon Inc.

12.1.1 Financial

12.1.2 Products/ Services Offered

12.1.3 SWOT Analysis

12.1.4 The SNS view

12.2 INC Escalon Medical Corp.

12.3 Eye PACS, LLC

12.4 IBM Corporation

12.5 INFINITT Healthcare Co. Ltd.

12.6 Koninklijke Philips N.V.

12.7 McKesson Corporation

12.8 Novarad

12.9 Onex Corporation (Carestream Health)

12.10 Siemens AG


13.Competitive Landscape

13.1 Competitive Benchmark

13.2 Market Share Analysis

13.3 Recent Developments



An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.


The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

Share Page
Start a Conversation

Hi! Click one of our member below to chat on Phone